C-Rad AB (publ) CRAD-B.ST
Nasdaq Stockholm · Healthcare · Medical Devices
24.00 SEK
+2.1%
2026-11-06
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for C-Rad
| SEK million | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 301 | 425 | 469 | 442 |
| EBITDA | 32 | 53 | 90 | 27 |
| Net income | 7 | 36 | 56 | 10 |
| Balance sheet | ||||
| Equity | 243 | 271 | 325 | 347 |
| Total debt | 4 | 2 | 9 | 9 |
| Cash | 122 | 129 | 151 | 171 |
| Net debt | −118 | −128 | −142 | −162 |
| Ratios and per share | ||||
| EBITDA margin | 10.6% | 12.5% | 19.2% | 6.1% |
| Profit margin | 2.5% | 8.4% | 12.0% | 2.4% |
| Return on equity | 3.1% | 13.1% | 17.4% | 3.0% |
| Earnings/share (SEK) | 0.22 | 1.05 | 1.68 | 0.31 |
| Book value/share (SEK) | 7.18 | 8.05 | 9.68 | 10.46 |
| Shares outstanding (M) | 34 | 34 | 34 | 33 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Key figures
| P/E | 76.2 |
| P/B | 2.3 |
| EV / EBITDA | 23.4 |
| Net debt / EBITDA | −6.0 |
| Return on equity | 3.0% |
| Profit margin | 2.4% |
| Beta 1Y | 0.84 |
| Revenue growth 1Y | −5.8% |
| Revenue CAGR 3Y | +13.6% |
| Earnings/share CAGR 3Y | +12.4% |
| ROE avg. 3Y | 11.2% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (SEK)
| 2026 | 0.10 |
Not investment advice. Figures may contain errors from the data source.